Skip to main content
RSC Advances logoLink to RSC Advances
. 2024 Aug 12;14(34):25077–25078. doi: 10.1039/d4ra90085e

Correction: Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo

Liying Chen a, Zhi Chen a,b,✉, Shuang Zheng a, Luhui Fan a, Lixin Zhu a,c, Jiandong Yu a, Chaoyuan Tang a, Qi Liu d, Yang Xiong a,✉
PMCID: PMC11317876  PMID: 39135976

Abstract

Correction for ‘Study on mechanism of elemene reversing tumor multidrug resistance based on luminescence pharmacokinetics in tumor cells in vitro and in vivo’ by Liying Chen et al., RSC Adv., 2020, 10, 34928–34937, https://doi.org/10.1039/d0ra00184h.


The authors regret that due to an image selection and processing error, the panel of group B-53 min and group C-93 min were incorrect in Fig. 4. The corrected version of Fig. 4 is provided below:

Fig. 1. BLI of MCF-7/DOXFluc tumor-bearing nude mice at different time points within 115 min after intraperitoneal injected d-luc with a dose of 100 mg kg−1 (n = 3). (A) PBS group (i.p., QD). (B) The low ELE concentration group (ELE 10 mg kg−1, i.p., QD). (C) The high ELE concentration group (ELE 25 mg kg−1, i.p., QD).

Fig. 1

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


Articles from RSC Advances are provided here courtesy of Royal Society of Chemistry

RESOURCES